All participants in the prescription drug supply chain deserve scrutiny, but weakening the mechanisms that extract price concessions will not lower drug spending. The more likely outcomes are gains for drug companies and less efficient pharmacies, and higher drug costs. Effects will be especially felt by seniors on Medicare and by smaller employers that lack the leverage to offset the law’s new constraints.
16:31, 27 февраля 2026Россия
，这一点在下载安装 谷歌浏览器 开启极速安全的 上网之旅。中也有详细论述
Bob’s world stacked twice
“If you actually believe in the AI revolution, 6G will be required. Resistance is futile.”